Key Points:
·Singapore recently implemented a nationwide campaign that led to the arrest of 195 individuals for violations related to e-cigarette products.
·Authorities discovered the presence of narcotics in the e-cigarette product Kpods.
·The government has now intensified its crackdown on e-cigarettes.
On September 1, 2025 - According to a report from time.news on August 31, Singapore authorities arrested a total of 195 individuals for e-cigarette-related violations in a series of nationwide enforcement actions. They also seized e-cigarette products "Kpods" containing dangerous drugs. The operation, which took place from August 15 to August 23, demonstrates the government's determination to address the rising trend of e-cigarettes and their associated health risks.
The operation carried out jointly by the Singapore Police Force and the Health Sciences Authority has revealed a concerning trend of individuals possessing and using e-cigarette products containing the powerful sedative, etizolam.
Singapore has strict laws regarding the import, sale, and use of e-cigarettes, with potential penalties including fines or imprisonment. This reflects the government's strong opposition to e-cigarettes.
Authorities deployed over 270 law enforcement officers to inspect more than 1,600 individuals from 151 public entertainment venues, including bars and KTV outlets. The operation spanned seven police districts and criminal investigation departments, with support from the Central Narcotics Bureau (CNB) and Health Sciences Authority (HSA).
A senior official stated, "These actions demonstrate the government team's commitment to maintaining public health and safety.
During the two-week operation, authorities seized over 340 e-cigarettes and related components. The age of those arrested ranged from 17 to 61 years old.
One of the most shocking discoveries in this case was the finding of etomidate in eleven e-cigarette pods confiscated from six individuals. These pods, known as "Kpods," signal a significant escalation in the dangers associated with e-cigarettes. Etomidate is a controlled substance commonly used for sedation and anesthesia in medical settings, and its illegal use can result in severe respiratory suppression, loss of consciousness, and even death.
The Health Sciences Authority (HSA) stated in a release, "The presence of tolylpyrazole in these e-cigarette products is highly concerning, highlighting the risks of purchasing and using unregulated e-cigarette products.
In addition to arrests related to e-cigarette crimes, law enforcement officers also detained 13 individuals suspected of other unspecified crimes during the enforcement action. This group included 10 males and 3 females, ranging in age from 19 to 47 years old. This demonstrates that the crackdown yielded results beyond its initial focus on e-cigarettes.
The two-week enforcement operation, as part of the government's overall strategy, demonstrates Singapore's tough stance on e-cigarettes and its emphasis on public health. Further investigations are ongoing.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
